Aerosolization of vasodilatory prostanoids: New therapeutic perspectives for the treatment of ARDS and severe chronic pulmonary hypertension?;Vasodilatative Prostanoide von der Infusion zum Aerosol: Neue Perspektiven für das ARDS und die primäre pulmonale Hypertonie

Intensivmedizin und Notfallmedizin

Volumn 34, Issue 5, 1997, Pages 370-380

  Walmrath, D ^a   Olschewski, H ^a   Grimminger, F ^a   Seeger, W ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Acute adult respiratory distress syndrome; Nitric oxide; Primary pulmonary hypertension; Prostacyclin

Indexed keywords

ILOPROST; NITRIC OXIDE; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN E1; PROSTAVASIN;

ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; DRUG EFFICACY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG CIRCULATION; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; REVIEW; TREATMENT OUTCOME; VASODILATATION;

EID: 0030792506     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050063     Document Type: Review

References (50)

1. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallworl J (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338:1173-1174
2. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W (1993) Aerosolized prostacyclin reduces pulmonary artery pressure and improves gas exchange. Lancet 342:961-962
3. 1 in patients with adult respiratory distress syndrome. Crit Care Med 12:528-529
4. 1 in patients with the adult respiratory distress syndrome. Chest 96:114-119
5. 1 and Survival in Patients with the Adult Respiratory Distress Syndrome. Ann Surg 203:371-378
6. 1 in the adult respiratory distress syndrome. Benefit for pulmonary hypertension and cost for pulmonary gas exchange. Am Rev Respir Dis 139:106-110
7. 1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology 70:601-606
8. Radermacher P, Santak B, Wüst HJ, Tarnow J, Falke KJ (1990) Prostacyclin and right ventricular functions in patients with pulmonary hypertension associated with ARDS Int Care Med 16:227-232
9. Richardson A, Wells FC, Branthwaite MA (1984) Use of prostacyclin and ultrafiltration in adult respiratory distress syndrome. Int Care Med 10.107-109
10. 1 in adult respiratory distress syndrome. Surgery 99:275-282
11. 1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Chest 98:405-410
12. 1 on the pulmonary circulation and oxygen delivery in patients with the adult respiratory distress syndrome. Int Care Med 11:61-64
13. Utsunomiya T, Krausz MM, Levine L, Shepro D, Hechtmann HB (1982) Thromboxane mediation of cardiopulmonary effects of embolism. J Clin Invest 70:361-368
14. 1 during continuous intravenous infusion in patients with adult respiratory distress syndrome. Am Rev Respir Dis 137:5-12
15. Bihari D, Smithies M, Gimson A, Tinker J (1987) The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Eng J Med 317:397-403
16. Pittet JF, Lacroix JS, Gunning K, Laverriere MC, Morel DR, Suter PM (1990) Prostacyclin but not phentolamine increases oxygen consumption and skin microvascular blood flow in patients with sepsis and respiratory failure. Chest 98:1467-1472
17. Rossaint R, Lopez S, Falke KJ, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399-405
18. Wysocki M, Delclaux C, Roupie E, Langeren O, Liu N, Herman B, Lemaire F, Brochard L (1994) Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bimesylate in the adult respiratory distress syndrome. Intensive Care Med 20:254-259
19. Gerlach H, Pappert D, Lewandowski K, Roissant R, Falke K (1993) Long term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 19:443-449
20. Puybasset L, Stewart T, Rouby J, Cluzel P, Mourgeon E, Belin MF, Arthaud M, Landault C, Viars P (1994) Inhaled nitric oxide reverses the increases in pulmonary vascular resistance induced by permissive hypercapnia in patients with acute respiratory distress syndrome. Anesthesiology 80:1254-1267
21. Roissant R, Gerlach H, Schmidt Ruhnke H, Pappert D, Lewandowski K, Steudel W, Falke K (1995) Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest: 107:1107-1115
22. Bigatello LM, Hurford WE. Kacmarek RM, Roberts JD, Zapol WM (1994) Prolonged inhalation of low concentrations on nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology 80:761-770
23. Young JD, Brampton WJ, Knighton JD, Finfer SR (1994) Inhaled nitric oxide in acute respiratory failure in adults. Br J Anesth 73:499-502
24. Puybasset L, Rouby J, Mourgeon E, Cluzel P, Souhil Z, Law-Koune JD, Stewart T, Devilliers C, Lu Q, Roche S, Kalfon P, Vicaut E, Viars P (1995) Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am J Respir Crit Care Med 152:318-328
25. Dellinger RP, Zimmerman JL, Hyers TM, Taylor RW, Straue RC, Hauser DL, Damask MC, Davis K, Criner GJ (1996) Inhaled nitric oxide in ARDS: preliminary results of a multicenter clinical trial. Crit Care Med 24:A29
26. Krafft P, Fridrich P, Fitzgerald RD, Koc D, Steltzer H (1996) Effectiveness of nitric oxide inhalation in septic ARDS. Chest 109:486-493
27. Walmrath D, Schneider T, Pilch J, Schermully R, Grimminger F, Seeger W (1995) Effects of aerosolized prostacyclin in severe pneumonia impact of fibrosis. Am J Respir Crit Care Med 151:724-730
28. Bein T, Pfeifer M, Riegger GAJ, Taeger K (1994) Continous intra-arterial measurement of oxygenation during aerosolized prostacyclin administration in severe respiratory failure. N Engl J Med 331:335-336
29. Walmrath D, Schneider T, Schermully R, Olschewski H, Grimminger F, Seeger W (1996) Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Dis Crit Care Med 153:991-996
30. Zwissler B, Kemming G, Habler O, Kleen M, Merkel M, Haller M, Briegel J, Weite M, Peter K (1996) Inhaled prostacyclin versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 154:1671-1677
31. Pappert D, Busch T, Gerlach H, Lewandowski K, Radermacher P, Roissant R (1995) Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology 82:1507-1511
32. D'Alonzo GE, Barst RJ, Ayres SM (1991) Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 115:343-349
33. Rich S, Kaufmann E, Levy PS (1992) The effect of high doses calcium channel blockers on survival in primary pulmonary hypertension. N Engl J Med 327:76-81
34. Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS (1994) Survival in primary pulmonary hypertension with long-term continous intravenous prostacyclin. Ann Int Med 107:409-415
35. Barst RJ, Rubin LJ, Long WA (1996) A comparison of continous intravenous epoprostenol (prostacyclin) with convential therapy for primary pulmonary hypertension. N Engl J Med 334:296-301
36. Snell GI, Salamonsen RF, Bergin P, Esmore DS, Khan S, Williams TJ (1995) Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end stage pulmonary hypertension. Am J Respir Crit Care Med 151(4):1263-1266
37. Sitbon O, Brenot F, Denjean A, Bergeron A, Parent F, Azarian R, Herve P, Raffestin B, Simonneau G (1995) Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. Am J Respir Crit Care Med 151:384-389
38. Rubin LJ (1997) Primary pulmonary hypertension. N Engl J Med 336:111-116
39. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS (1994) Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 90(6):2780-2785
40. Bocchi EA, Bacal F, Auler JOC jr, Carmone MJ de C, Bellotti G, Pileggi F (1994) Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol 74:70-72
41. Berner M, Beghetti M, Ricou B (1993) Relief of severe pulmonary hypertension after closure of a large ventricular septal defect using low dose inhaled nitric oxide. Int Care Med 19:75-77
42. Grover R, Murdoch I, Smithies M, Bihari D (1992) Nitric oxide during hand ventilation in patient with acute respiratory failure. Lancet 340:1038-1039
43. Miller OI, Tang SF, Keech A, Celermajer DS (1995) Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 346:51-52
44. Lavoie A, Hall JB, Olson DM, Wylam ME (1996) Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Crit Care Med 153:1985-1987
45. Assreuy J, Cunha FQ, Liew FY, Moncada S (1993) Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 108:833-837
46. Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W (1996) Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 124:820-824
47. 2 as markers of altered surfactant metabolism. Lung 172:61-72
48. Glutton-Brock J (1967) Two cases of poisoining by contamination of nitrous oxide with the higher oxide of nitrogen during anaesthesia. Br J Anaesth 39:393-404
49. Högman M, Frostell C, Arnberg H, Hedenstierna G (1993) Bleeding time prolongation and NO inhalation. Lancet 341:1664-1665
50. Nguyen T, Brunson D, Crespi CL (1992) DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 89:3030-3034